Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

Published:2021-02 Issue:2 Volume:22 Page:256-266
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Quénet François,Elias Dominique,Roca Lise,Goéré Diane,Ghouti Laurent,Pocard Marc,Facy Olivier,Arvieux Catherine,Lorimier Gérard,Pezet Denis,Marchal Frédéric,Loi Valeria,Meeus Pierre,Juzyna Beata,de Forges Hélène,Paineau Jacques,Glehen Olivier,MARIANI Pascale,BRIGAND Cécile,BEREDER Jean-Marc,MSIKA Simon,PORTIER Guillaume,RAT Patrick

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer;Segelman;Br J Surg,2012

2. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841;Franko;J Clin Oncol,2012

3. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database;Franko;Lancet Oncol,2016

4. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug;Koga;Cancer Res,1984

5. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts;Elias;Hepatogastroenterology,1994

Cited by 395 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer: A long way to go;European Journal of Cancer;2024-03

2. Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative;Annals of Surgical Oncology;2024-02-03

3. Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study;Cytotherapy;2024-02

4. Recurrence and Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Synchronous and Metachronous Peritoneal Metastases of Colorectal Origin;Cancers;2024-02-01

5. Oncological outcomes and hospitalization cost of hyperthermic intraperitoneal chemotherapy (HIPEC) open and closed abdomen techniques: Results from two French expert centers;European Journal of Surgical Oncology;2024-02